AI Proves Useful for Ovarian Cancer Diagnosis
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
FRIDAY, Jan. 3, 2025 -- AI can outperform human doctors when it comes to identifying ovarian cancer from ultrasound images.
A new study published in the journal Nature Medicine shows that specially trained AI program achieved an accuracy rate of more than 86% in identifying ovarian cancer by scanning ultrasounds, compared to just under 83% for human experts and nearly 78% for non-expert examiners.
“Ovarian tumors are common and are often detected by chance,” researcher Elisabeth Epstein, a senior physician with the Stockholm South General Hospital’s Department of Clinical Science and Education, said in a news release from the Karolinska Institute in Sweden.
These results suggest that AI “can offer valuable support in the diagnosis of ovarian cancer, especially in difficult-to-diagnose cases and in settings where there’s a shortage of ultrasound experts,” Epstein said.
For the study, researchers trained an AI program to be able to tell the difference between benign and malignant ovarian lesions, using more than 17,000 ultrasound images from nearly 3,700 patients across 20 hospitals in eight countries.
The AI program also cut back on the need for expert referrals, by backing up human doctors, researchers found.
In a simulated care scenario, support from the AI cut the number of referrals by 63% and the misdiagnosis rate by 18%.
Overall, these results show that AI could contribute to faster and more cost-effective care for patients with ovarian lesions, researchers concluded.
However, the research team noted that more studies are needed to validate their findings and fully explore the potential helpfulness of AI.
They are now conducting research to evaluate the everyday clinical safety and usefulness of the program, and are planning for a clinical trial to examine the AI’s effect on patient management and health care costs.
“With continued research and development, AI-based tools can be an integral part of tomorrow’s healthcare, relieving experts and optimizing hospital resources, but we need to make sure that they can be adapted to different clinical environments and patient groups,” co-lead researcher Filip Christiansen, a doctoral student in Epstein’s research group at Karolinska Institute, said in a news release.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-04 06:00
Read more
- Early Anti-TNFα Therapy Cuts Perianal Fistula Complications in Pediatric Crohn Disease
- Every Cigarette Smoked Could Cost You 22 Minutes of Life, Research Says
- Breastfeeding Initiation Rates Increased During 2022 Infant Formula Crisis
- Children With Primary Ciliary Dyskinesia Likely to Have Asthma
- Guidance Issued for Use of Metformin to Prevent Antipsychotic-Induced Weight Gain
- Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions